Bonafide® Health Launches Thermella™, The First and Only Hormone-Free, Prescription-Free NK3R Antagonist for Menopause Symptom Management – Delivers Groundbreaking Clinical Research at The Menopause Society’s Annual Meeting New York, NY, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Bonafide Health, LLC, a women’s healthcare company committed to providing effective and clinically studied solutions for common perimenopause and...

Bonafide Health Issues Findings of 4th Annual State of Menopause Study, Trends Reveal Positive Progress in Open Discussion and Overcoming Stigma, But Confusion and Misperceptions Remain Rampant New York, NY, July 08, 2024 (GLOBE NEWSWIRE) -- Bonafide Health, LLC, a women’s healthcare company that provides hormone-free, clinically researched solutions to effectively relieve perimenopause...

Bonafide Health’s 3rd Annual 'State of Menopause' Survey Reveals Startling Lack of Menopause Education NEW YORK, Oct. 11, 2023 (GLOBE NEWSWIRE) --         Bonafide® Health, LLC, a women’s healthcare company offering naturally powerful solutions to manage common perimenopause and menopause symptoms,...